FRANK FAZIO is Vice President of Distribution and Licensing Services of Porzio Life Sciences, LLC. In this role, Mr. Fazio works with both emerging and established pharmaceutical companies in obtaining the necessary state distribution licensure for legend and controlled drugs, medical devices, and over-the-counter products. Mr. Fazio also works with companies as an outsource solution for the management of renewal licensure and audits the licensure status of pharmaceutical companies and their vendors. Mr. Fazio also collaborates with Regulatory Analysts to manage the content of products.
Mr. Fazio is also a principal of Porzio, Bromberg & Newman P.C. and a registered pharmacist in the State of New Jersey. As a member of the firm’s Pharmaceutical Marketing and Sales Compliance department, his legal practice includes conducting third-party vendor PDMA compliance audits, counseling pharmaceutical manufacturers and wholesale distributors on licensing, record-keeping and pedigree issues, and providing guidance on OIG compliance, off-label promotion and other regulatory issues involving sales and marketing practices. A seasoned litigator, Mr. Fazio also defends manufacturers in pharmaceutical and medical device product liability litigation. Mr. Fazio is a frequent speaker on topics involving state, federal and international regulation of pharmaceutical sales and marketing practices.
Mr. Fazio received his J.D. from Seton Hall University School of Law, where he graduated cum laude in 1989. He earned his B.S. in Pharmacy from The University of New Mexico in 1986. Mr. Fazio is a member of the American Pharmacists’ Association and the New Jersey Pharmaceutical Association. He is a Fellow of the American Society of Pharmacy Law and a Fellow of the Center for International Legal Studies.
- Moderator, "Compliance Champion Exchange," CBI's 7th Annual West Coast Compliance Congress, San Francisco, CA, November 9, 2016.
- "State Licensing and Other Compliance Considerations in Planning a U.S. Launch," BioWales, Cardiff, Wales, March 2, 2016.